BYANNLI 1000mg long-release injection suspension medication leaflet

N05AX13 paliperidone • Nervous system | Antipsychotics | Other antipsychotics

Paliperidone is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics and works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.

The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.

Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.

General data about BYANNLI 1000mg

Substance: paliperidone

Date of last drug list: 01-06-2025

Commercial code: W68386001

Concentration: 1000mg

Pharmaceutical form: long-release injection suspension

Quantity: 1

Product type: original

Price: 6529.12 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: JANSSEN PHARMACEUTICA N.V. - BELGIA

Holder: JANSSEN CILAG INTERNATIONAL NV - BELGIA

Number: 1453/2020/008

Shelf life: 2 years

Concentrations available for paliperidone

1000mg, 100mg, 12mg, 150mg, 175mg, 25mg, 263mg, 350mg, 3mg, 50mg, 525mg, 6mg, 700mg, 75mg, 9mg

Compensation lists for BYANNLI 1000mg CILAG

G15 (C1) - Mental illness

Price

Copayment

Patient

6529.12 RON

6529.12 RON

0.00 RON